Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2009 10:06 ET | Source: Enobia Pharma Inc.

Enobia Announces Positive Interim Clinical Results With ENB-0040

MONTREAL, June 11, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that results from two early-stage...
June 11, 2009 10:06 ET | Source: Enobia Pharma Inc.

Experimental Drug Strengthens Bones in Infants With Severe Hypophosphatasia

Shriners Hospitals for Children's Dr. Michael Whyte Presents First Efficacy and Safety Results of Targeted Enzyme Replacement Therapy in Patients With Rare Genetic Bone Disease ...
May 19, 2009 09:58 ET | Source: Enobia Pharma Inc.

Enobia Pharma's ENB-0040 Receives FDA Fast Track Designation

MONTREAL, May 19, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that the U.S. Food and Drug...